Botulinum neurotoxin injection after total laryngectomy

被引:0
|
作者
Hoffman, HT [1 ]
Fischer, H [1 ]
VanDenmark, D [1 ]
Peterson, KL [1 ]
McCulloch, TM [1 ]
Karnell, LH [1 ]
Funk, GF [1 ]
机构
[1] NATL CTR VOICE & SPEECH,IOWA CITY,IA
关键词
botulinum neurotoxin; tracheoesophageal puncture speech; laryngectomy;
D O I
10.1002/(SICI)1097-0347(199703)19:2<92::AID-HED2>3.0.CO;2-P
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: One of several causes of tracheoesophageal puncture (TEP) speech failure after total laryngectomy is disturbance in relaxation of the pharyngoesophageal (PE) segment. We introduce the use of chemical denervation of the PE segment through botulinum neurotoxin (Botox(R)) injection to improve TEP speech. Methods: An analysis was performed on eight patients who received Botox(R) injections for TEP speech problems after total laryngectomy at the University of Iowa between June 4, 1991 and August 8, 1994. Retrospective chart review identified the evolution of pretreatment evaluation and injection technique which became standardized in April 1992. Prospective evaluation of results was recorded by a single speech pathologist who subjectively identified the response to Botox(R) in all patients and recorded pressure readings at the tracheostoma site during speech in 6 patients. Results: Seven of the eight patients were noted to have improved TEP speech following injection. Five of these seven patients experienced substantially improved speech, three of whom had no ability to produce speech prior to the Botox(R) injection. Conclusion: Botox(R) injection is a safe and effective method of improving TEP speech in selected patients with disturbed relaxation of pharyngoesophageal segment. (C) 1997 John Wiley & Sons, Inc.
引用
收藏
页码:92 / 97
页数:6
相关论文
共 50 条
  • [1] Botulinum toxin injection to improve tracheoesophageal speech after total laryngectomy
    Zormeier, MM
    Meleca, RJ
    Simpson, ML
    Dworkin, JP
    Klein, R
    Gross, M
    Mathog, RH
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1999, 120 (03) : 314 - 319
  • [2] Paradoxical masseteric bulging after botulinum neurotoxin type A injection
    Sandhu, Shaiba
    Shaefer, Jeffry
    BMJ CASE REPORTS, 2024, 17 (05)
  • [3] ULTRASTRUCTURAL CHANGES IN HUMAN MASSETER MUSCLES AFTER BOTULINUM NEUROTOXIN A INJECTION
    Ma, Fushun
    Zhai, Zhaohui
    Zhu, Shunwen
    Tang, Shengjian
    MUSCLE & NERVE, 2018, 57 (01) : 96 - 99
  • [4] Sonoanatomy of the Nasal Ala for Botulinum Neurotoxin Injection
    Yi, Kyu-Ho
    Kim, Soo-Bin
    Hu, Hyewon
    Frank, Konstantin
    Cartier, Hugues
    Garson, Sebastien
    Kim, Hee-Jin
    JOURNAL OF COSMETIC DERMATOLOGY, 2025, 24 (04)
  • [5] Guidelines for Botulinum Neurotoxin Injection for Facial Contouring
    Yi, Kyu-Ho
    Lee, Hyung-Jin
    Hur, Hye-Won
    Seo, Kyle K.
    Kim, Hee-Jin
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 150 (03) : 562E - 571E
  • [6] Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report
    Kilboz, Bekir Burak
    Ervatan, Zekeriya
    Dumlu, Ridvan
    Akan, Onur
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (10) : 3394 - 3396
  • [7] Micro/nanostructural Characteristic Changes in the Mandibles of Rats after Injection of Botulinum Neurotoxin
    Kusaba, Gaku
    Matsunaga, Satoru
    Kitamura, Kei
    Kasahara, Masaaki
    Shimoo, Yoshiaki
    Abe, Shinichi
    Nakano, Takayoshi
    Ishimoto, Takuya
    Hikita, Atsuhiko
    Nojima, Kunihiko
    Nishii, Yasushi
    JOURNAL OF HARD TISSUE BIOLOGY, 2021, 30 (02) : 183 - 191
  • [8] Treatment of Camptodactyly Using Injection of Botulinum Neurotoxin
    Urban, Maciej
    Rutowski, Roman
    Urban, Jozef
    Mazurek, Piotr
    Kulinski, Sebastian
    Gosk, Jerzy
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 23 (03): : 399 - 402
  • [9] The Anatomical Basis of Paradoxical Masseteric Bulging after Botulinum Neurotoxin Type A Injection
    Lee, Hyung-Jin
    Kang, In-Won
    Seo, Kyle K.
    Choi, You-Jin
    Kim, Seong-Taek
    Hu, Kyung-Seok
    Kim, Hee-Jin
    TOXINS, 2017, 9 (01):
  • [10] Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A
    Tiigimae-Saar, Janne
    Tamme, Tiia
    Rosenthal, Marika
    Kadastik-Eerme, Liis
    Taba, Pille
    NEUROLOGICAL SCIENCES, 2018, 39 (05) : 871 - 877